$GILD Recent Headlines Investors warm up to Gilead's test

New Post Public Reply Private Reply Replies (0) Message Board

Dec 21, 2013 at 4:46 PM

$GILD Recent Headlines

Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 4:07 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 3:59 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 7:21 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Best Buy, Gilead Sciences lead S&P 500 gainers 3:05 p.m. Oct. 10, 2013 - Polya Lesova
Gilead, Acura stand out on up day for stocks, Quest tumbles 10:27 a.m. Oct. 10, 2013 - Russ Britt
Gilead ends leukemia study after positive results 4:10 p.m. Oct. 9, 2013 - MarketWatch.com
Citrix, Ruby Tuesday shares fall after hours 4:06 p.m. Oct. 9, 2013 - Wallace Witkowski
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey

2 Big Biotechs Moving Up On News 12:10 p.m. Dec. 20, 2013 - Seeking Alpha
Cramer's Mad Money - Themes That Will Work For 2014 (12/19/13) 6:23 a.m. Dec. 20, 2013 - Seeking Alpha
Jim Cramer's Top Stock Picks: AAPL CAT CX VMC CELG GILD 6:00 a.m. Dec. 20, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Some 'Buys' for the New Year 8:22 p.m. Dec. 19, 2013 - TheStreet.com
Positive Data on Gilead's Sovaldi - Analyst Blog 5:20 p.m. Dec. 19, 2013 - Zacks.com
Stock Market News for December 19, 2013 - Market News 10:06 a.m. Dec. 19, 2013 - Zacks.com
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014 7:37 a.m. Dec. 19, 2013 - 247WallSt.com
Trade of the Day: Gilead Sciences (GILD) 4:08 a.m. Dec. 19, 2013 - InvestorPlace.com
Gilead's Sovaldi Holds Promise - Analyst Blog 4:30 p.m. Dec. 18, 2013 - Zacks.com
Gilead's Next Hepatitis C Drug A Hit In Trials 11:32 a.m. Dec. 18, 2013 - Investors Business Daily
Enanta falls after Gilead HCV data 10:56 a.m. Dec. 18, 2013 - Seeking Alpha
Gilead Offers Strong Data on Hepatitis C Treatment 10:12 a.m. Dec. 18, 2013 - WSJ.com
Gilead releases positive data from sofosbuvir/ ledipasvir HCV trials 9:30 a.m. Dec. 18, 2013 - Seeking Alpha
Waiting for a Signal From Gilead 9:00 a.m. Dec. 18, 2013 - RealMoney.com
Today's Pre-Market Trading Very Positive For Gilead (GILD) 8:58 a.m. Dec. 18, 2013 - TheStreet.com
Why Investors Are Writing Off Infinity Pharma 8:00 a.m. Dec. 18, 2013 - TheStreet.com
Piper Jaffray Top Stocks to Buy for 2014 7:44 a.m. Dec. 18, 2013 - 247WallSt.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard 5:06 p.m. Dec. 17, 2013 - TheStreet.com
Label of Gilead's Complera Expanded - Analyst Blog 12:00 p.m. Dec. 16, 2013 - Zacks.com
Gilead Announces Health Canada Notice of Compliance for Sovaldi for Treatment of Chronic Hepatitis C 7:39 a.m. Dec. 16, 2013 - benzinga.com

Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera(R) for Patients Switching from a Stable Regimen 4:30 p.m. Dec. 13, 2013 - BusinessWire
HealthStat Rx: Curing Hepatitis C (HCV) With Confidence 10:07 a.m. Dec. 12, 2013 - BusinessWire
Here to Track Insider Trading of Gilead Sciences, Microsoft, Halliburton 8:55 a.m. Dec. 11, 2013 - PR Newswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology 11:00 a.m. Dec. 9, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin's Lymphoma 6:00 p.m. Dec. 8, 2013 - BusinessWire
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 6:30 p.m. Dec. 7, 2013 - BusinessWire
U.S. Food and Drug Administration Approves Gilead's Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 4:19 p.m. Dec. 6, 2013 - BusinessWire
Gilead Sciences to Present at the NASDAQ OMX 30th Investor Program on Tuesday, December 3 5:00 p.m. Dec. 2, 2013 - BusinessWire
Critical Alerts For General Electric, Gilead Sciences, Morgan Stanley, Qualcomm, and Adobe Released By InvestorsObserver 9:31 a.m. Dec. 2, 2013 - PR Newswire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tigo Energy Lawsuit: Shareholders' Fight for Justice

Energy Optimism or Illusion? Is it a bright future when projections fizzle out faster than a lukewarm coffee on a cold morning? If you snapped up shares of Tigo Energy (NASDAQ: TYGO) thinking you were hitching your wagon to a rising solar star, the latest class action might just feel like a gut punch. Tangled Partnership Promises Let's cut to the core of the issue. Tigo...

Sungrow PowerStack 3.0: Pioneering a New Energy Era

Pioneering with PowerStack 3.0: A Bold Move Sungrow's latest unveiling at the Global Energy Pioneer Summit 2026 has set the stage for a revolution in the commercial and industrial (C&I) energy storage sector. The PowerStack 3.0 isn't just another upgrade—it's a strategic leap into the future with its Scene-in-One system integration, aimed at adapting to the ever-diverse...

First Move-Ins at Modera Ridgeline Begin Soon

Mill Creek Sets Up Shop in McKinney You ever watch these neighborhoods sprout up like they’re out of nowhere? Seems like every time you blink, there’s another bunch of homes cropping up. Mill Creek Residential’s latest offering, Modera Ridgeline, joins the ranks with its 325 homes getting ready for squatters who prefer a bit of nature with their suburban sprawl....

Fibocom & Suntek Tackle Smart Lawn Mower Market

Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...

Yael Eckstein Honored for Advancing Faith Collaborations

Recognition for Bridging Communities It's not every day you hear about someone getting a pat on the back as broad as a lifetime achievement award. Yet, Yael Eckstein, President and Global CEO of the International Fellowship of Christians and Jews (The Fellowship), managed just that during an elegant gala in Jerusalem. The Black Christian Leadership Council on Israel...

Eli Radiopharma Clinches Big Series A, Eyes Milestones

Making Waves in Radiopharmaceuticals Some days, it's not just about the numbers—it’s about the shift in an entire field. Eli Radiopharma just closed a grand RMB 400 million Series A financing, paving a path that could redefine radiopharmaceuticals. Kinfolk over at Huagai Capital led the charge, teaming up with Bayland Capital and a throng of other backers. They’re...

JEM Global Brings Smart Outdoor Lights to Walmart

Walmart's New Lighting Surprise for the Holidays Throw your boring old holiday lights out the window because JEM Global's just teamed up with Walmart to unleash the Monster Smart 150-Foot RGBIC + Multi-White Permanent Outdoor Lights. Yeah, that means a facelift for your house without breaking the bank—$114.99 to be exact, right off the virtual shelves on Walmart.com and...

OpenAI Expands ChatGPT Ads: Aleph Partnership Key

OpenAI Teams Up with Aleph for Global Reach OpenAI's no rookie in the tech game, but its move to bolster ChatGPT's ad presence with Aleph is like adding a rocket to turbocharge its engine. With Aleph as a partner, OpenAI's not just dipping a toe in the waters of global advertising—they're diving headfirst into 44 countries. This isn't just about slapping ads on more...

Kodiak's Conferences: Investor Eyes on New Therapeutics

Kodiak Sciences Gears Up for Global Investor Showdowns Alright, here comes another biotech contender about to hit the stages at some heavy-hitting conferences, and it’s one that’s got its sights locked on the retina. November and December will see Kodiak Sciences (Nasdaq: KOD) showcasing their stuff at three major investor conferences, with London and Miami as their...

Peak 10's $500M Boost From U.S. Bank Shakes Up Oil Sector

Riding the Peak 10 Energy Wave Alright, let's cut to the chase. Peak 10 Energy has just announced a whopper of a deal—a $500 million acquisition finance facility, courtesy of U.S. Bank. This ain't small potatoes. It's a strategic move designed to gobble up some juicy oil and gas asset packages across the United States. We're talking proved developed producing (PDP)...